Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation

NCT04133168 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04133168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04133168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
June 24, 2020
Completion date
August 17, 2023
Enrollment
458 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation